Full Name
Zdraveska, Marija
Vernacular Name
Zdraveska M.
 
Variants
Zdraveska M
M. Zdraveska
Marija Zdraveska
Lazarevska Marija
Lazarevska M
Здравеска Марија
Здравеска М
Лазаревска Марија
Лазаревска М
Marija Zdravevska
 
Main Affiliation
 
Loading... 2 0 5 0 false
Loading... 3 0 5 0 false

Refined By:
Author:  Monreal M
Date Issued:  2017

Results 1-6 of 6 (Search time: 0.014 seconds).

PreviewTitleAuthor(s)Issue DateType
1Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism.Moustafa F; Giorgi Pierfranceschi M; Di Micco P; Bucherini E; Lorenzo A; Villalobos A; Nieto JA; Valero B; Sampériz ÁL; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2017Article
2Low discriminating power of the modified Ottawa VTE risk score in a cohort of patients with cancer from the RIETE registryAlatri A; Mazzolai L; Font C; Tafur A; Valle R; Marchena PJ; Ballaz A; Tiraferri E; Font L; Monreal M; Riete Investigators; Bosevski M ; Zdraveska M 2017Article
3Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.Tzoran I; Papadakis M; Brenner B; Fidalgo Á; Rivas A; Wells PS; Gavín O; Adarraga MD; Moustafa F; Monreal M; Registro Informatizado de Enfermedad TromboEmbólica Investigators; Bosevski M ; Zdraveska M 2017Article
4Predictors of active cancer thromboembolic outcomes. RIETE experience of the Khorana score in cancer-associated thrombosis.Tafur AJ,; Caprini JA,; Cote L; Trujillo-Santos J; Del Toro J,; Garcia-Bragado F; Tolosa C,; Barillari G,; Visona A,; Monreal M; RIETE Investigators; Bosevski, M ; Zdraveska M 2017Article
5Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimensTrujillo-Santos J; Di Micco P; Dentali F; Douketis J; Díaz-Peromingo JA; Núñez MJ; Cañas I; Mastroiacovo D; Saraiva de Sousa M; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2017Article
6Uterine bleeding during anticoagulation in women with venous thromboembolism.Moustafa F,; Fernández S,; Fernández-Capitán C,; Nieto JA,; Pedrajas JM,; Visoná A,; Valero B,; Marchena PJ,; Braester A,; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2017Article